Nabiha Saklayen is CEO & co-founder of Cellino, a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies. Cellino is building a proprietary platform technology that makes personalized stem cell-derived therapies scalable for the first time.
Nabiha was selected as a Pioneer in MIT Tech Review’s 35 Innovators under 35 list for her inventions in cellular laser editing and is on the 2019 Forbes 30 under 30 List for Healthcare. She received her Ph.D. in Physics from Harvard University as a Howard Hughes Medical Institute (HHMI) International Fellow. Nabiha has published several peer-reviewed articles in the field of pulsed-laser delivery to cells.